Found: 14
Select item for more details and to access through your institution.
Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment.
- Published in:
- Stem Cells International, 2016, p. 1, doi. 10.1155/2016/7053872
- By:
- Publication type:
- Article
Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 4, p. 1098, doi. 10.3390/ijms19041098
- By:
- Publication type:
- Article
miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer.
- Published in:
- Oncology Letters, 2017, v. 14, n. 2, p. 1355, doi. 10.3892/ol.2017.6303
- By:
- Publication type:
- Article
A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-63
- By:
- Publication type:
- Article
A phase lotal study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study).
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-108
- By:
- Publication type:
- Article
A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome.
- Published in:
- 2014
- By:
- Publication type:
- journal article
A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study).
- Published in:
- 2014
- By:
- Publication type:
- journal article
Overexpression of miR-221 and miR-222 in the cancer stroma is associated with malignant potential in colorectal cancer.
- Published in:
- Oncology Reports, 2018, v. 40, n. 3, p. 1621, doi. 10.3892/or.2018.6575
- By:
- Publication type:
- Article
IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides.
- Published in:
- Oncology Reports, 2018, v. 39, n. 5, p. 2385, doi. 10.3892/or.2018.6288
- By:
- Publication type:
- Article
MicroRNA-6826 and -6875 in plasma are valuable non-invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer.
- Published in:
- Oncology Reports, 2017, v. 37, n. 1, p. 23, doi. 10.3892/or.2016.5267
- By:
- Publication type:
- Article
Characterization of the T cell repertoire by deep T cell receptor sequencing in tissues and blood from patients with advanced colorectal cancer.
- Published in:
- Oncology Letters, 2016, v. 11, n. 6, p. 3643, doi. 10.3892/ol.2016.4465
- By:
- Publication type:
- Article
miR-125b-1 and miR-378a are predictive biomarkers for the efficacy of vaccine treatment against colorectal cancer.
- Published in:
- Cancer Science, 2017, v. 108, n. 11, p. 2229, doi. 10.1111/cas.13390
- By:
- Publication type:
- Article
Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS- PC study.
- Published in:
- Cancer Science, 2017, v. 108, n. 1, p. 73, doi. 10.1111/cas.13113
- By:
- Publication type:
- Article
Prediction of the efficacy of immunotherapy by measuring the integrity of cell-free DNA in plasma in colorectal cancer.
- Published in:
- Cancer Science, 2016, v. 107, n. 12, p. 1825, doi. 10.1111/cas.13085
- By:
- Publication type:
- Article